Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in Greece.

Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
    • Dyslipidemia
    • Atherothrombosis
  • Diabetes
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Diabetes
PRODUCTS
  • PRODUCTS
  • Clexane®
  • Plavix®
  • Praluent®
    • Praluent®
    • Οδηγίες χρήσης συσκευής Praluent
  • Toujeo®
Home | go to homepage
Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
    • Dyslipidemia
    • Atherothrombosis
  • Diabetes
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Diabetes
PRODUCTS
  • PRODUCTS
  • Clexane®
  • Plavix®
  • Praluent®
    • Praluent®
    • Οδηγίες χρήσης συσκευής Praluent
  • Toujeo®
  • LOGIN
  • REGISTER
  • SEARCH
    • Home
    • Science
    • Inspiration and Innovation

    Inspiration and Innovation

    Get inspired and stay on the cutting edge of innovation with these resources.

    Filters

    Therapeutical Areas
    Cardiovascular
    Diabetes
    Atopic Dermatitis
    Asthma
    Nasal Polyps
    Type of Content
    Watch
    Listen
    Read

    The European Commission has approved an additional indication for Plavix®

    TIA& Stroke Early to Late Management

    Plavix Press Release

    T1DM Mini-Series: Severe hypoglycaemia compromises the achievement of glycaemic control

    T1DM Mini-Series: Relevance of Edition JUNIOR trial results for the HCP and PTS life

    T1DM Mini-Series: How Does Hypoglycaemia impact the life of people with T1 Diabetes?

    T1DM Mini-Series: The main challenge for the kids and adolescents with T1

    T1DM Mini-Series: How to Avoid Hypoglycaemia in People with T1 Diabetes?

    T1DM Mini-Series: Edition JUNIOR trial results

    Home | go to homepage

    Sanofi Aventis Α.Ε.Β.Ε. Syngrou Av. 348, Building A, Kallithea, Attica, Greece, 176 74
    Tel: +30 2109001600
    For further Medical Information:
    Tel: +30 2109001600 | Email: MedicalInformation.Greece@sanofi.com
    To report an adverse event:
    Tel: +30 2109001600 | Email: PV-Greece@sanofi.com
    To report any product technical complaints:
    Tel: +30 2109001696 (during business days & hours) or +30 2109001600 (24/7) | Email: QA.Greece@Sanofi.com

    MAT-GR-2200026/v1.0/Jan2022

    • Legal notice
    • Cookie policy
    • Privacy policy
    • Sitemap

    YOU WILL NOW BE LEAVING THE SITE

    By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
    Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

    Continue
    This website is intended exclusively for healthcare professionals residing and/or working in Greece.
     
    Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.